stoxline Quote Chart Rank Option Currency Glossary
  
Sintx Technologies, Inc. (SINT)
3.1145  -0.116 (-3.58%)    10-07 15:46
Open: 3.25
High: 3.25
Volume: 12,963
  
Pre. Close: 3.23
Low: 3.11
Market Cap: 2(M)
Technical analysis
2024-10-07 3:17:57 PM
Short term     
Mid term     
Targets 6-month :  6.26 1-year :  8.15
Resists First :  5.36 Second :  6.98
Pivot price 3.38
Supports First :  2.75 Second :  2.28
MAs MA(5) :  3.18 MA(20) :  3.44
MA(100) :  5.85 MA(250) :  33.75
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  9.4 D(3) :  9.4
RSI RSI(14): 41.2
52-week High :  180 Low :  2.75
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SINT ] has closed above bottom band by 15.4%. Bollinger Bands are 88.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 78 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.25 - 3.27 3.27 - 3.28
Low: 3.08 - 3.09 3.09 - 3.11
Close: 3.21 - 3.23 3.23 - 3.26
Company Description

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Headline News

Tue, 01 Oct 2024
SINTX Announces Key Executive Promotions: Ryan Bock, PhD, - GlobeNewswire

Tue, 01 Oct 2024
SINTX Announces Key Executive Promotions: Ryan Bock, PhD, Named Chief Technology Officer and Ann Kutsch Promoted to President of SINTX TA&T - StockTitan

Thu, 19 Sep 2024
SINTX Announces Completion of $3.1 Million ATM Equity Public Offering - StockTitan

Mon, 09 Sep 2024
SINTX Receives Notice of Allowance for United States Patent - GlobeNewswire

Mon, 09 Sep 2024
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial - StockTitan

Mon, 09 Sep 2024
Why SINTX Technologies Stock Is Up 100% Today - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 1 (M)
Held by Insiders 747270 (%)
Held by Institutions 3 (%)
Shares Short 56 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin -275.2 %
Operating Margin -275.9 %
Return on Assets (ttm) -40.2 %
Return on Equity (ttm) -76 %
Qtrly Rev. Growth 69 %
Gross Profit (p.s.) 0
Sales Per Share 2.23571e+006
EBITDA (p.s.) -7.13571e+006
Qtrly Earnings Growth 903.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -1.57
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0.37
Stock Dividends
Dividend 0
Forward Dividend 68980
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android